1 FDA Thailand By HIV Module/Marketing Group Mr. Manaswee Arayasiri
Dec 23, 2015
3
Introduction
• About FDA Thailand
• Role and Responsibility
• Relating Acts
• Administration of Acts
• Organization of FDA for controlling
4
About FDA Thailand
• Consumer protection activities on food and drugs have begun in Thailand since 1909
• Established in 1922 as a Narcotic division
• In 1937, the agency renamed to Food and Drug division
5
About FDA Thailand
• In 1953, the agency renamed to Division of Food and Drug Control.
• In 1974, Division of Food and Drug Control was promoted to be the Office of Food and Drug Administration, having the status as department of Ministry of Public Health.
6
Roles and Responsibilities
• Major is to ensure that health products(i.e. food, drug etc.) available to consumers are of standard quality, efficacy, and safety.
7
Roles and Responsibilities
• Main tasks are to control and monitor both pre- and post-marketing phases of manufacture, import, transport, storage and sale
8
Relating Act
• Drug Act 1987 (5th revision)
• Food Act 1979
• Cosmetic Act 1992
• Narcotic Act 1987 (3rd revision)
9
Relating Act
• Psychotropic Substances Act 1992(3rd revision)
• Volatile Substances Act 1990
• Medical Devices Act 1988
10
Administration of Acts
• Committees of drug, food, narcotics, cosmetics etc. follow Acts
• Committees to develop policies and promote technological development on food, drugs and chemical safety
11
Organization of FDA for controlling
• Drug control division
• Food control division
• Toxic substance control division
• Narcotic control division
• Cosmetic control division
• Medical device control division
• Public relation and Advertisement control division
13
How to register drug
• Contact Drug control division FDA Thailand Ministry of Public Health Nonthaburi Thailand
• E-mail address: www.fda.moph.go.th
14
Drug registration procedure
• In this HIV module, Assume use procedure of new drugs registration in term of Generic drug
• Generic drug is an imitation of an original brand-name drug, when the patent or trademark protection on original brand-name drug expires
15
Drug registration procedure
• Step 1 : Asking permission for Bioequivalence study
• Step 2 : Asking permission for produce/order sample drug for study
• Step 3 : Asking permission for register Pharmacopoeia
16
Definition
• Pharmacopoeia is a book described drugs; one issued by an officially recognized authority and serving as standard
• Bioequivalence study is study drugs in term of therapeutic response compare between innovator product and original product
18
Document for application
• Label every size of container
• Accompany literature
• Clinical trial report
• Certificate of free sale
• Detail of protocol for Bioequivalence study
19
Procedure
The subcom m ittee consider
Experts consider
Officers consider
Send protocol to asking for B ioequivalence study
20
Procedure (Continue)
Approve
Approve Not approve
Reconsider
Correct/adjust Not approve
The subcom m ittee consider
22
Document for application
• Label every size of container
• Accompany literature
• Certificate of GMP
• Certificate of free sale
• Certificate of Analysis
23
Definition
• Certificate of GMP is certificate for factory about Manufacturing practice follow WHO practice
• Certificate of Free Sale is document present that drug is legally sold in the country of origin
24
Definition
• Certificate of Analysis is report present result of pharmaceutical product standard checking
25
Procedure
Approve for production/order sam ple drug
Officers consider
Producer asking for production/order sam ple drug
Approve for B ioequivalence study
26
Procedure (Continue)
Asking for register pharm acopoeia
Result of B ioequivalence study
Producer can begin B ioequivalence study
28
Document for application
• Sample drugs
• Label every size of container
• Accompany literature
• Result of Bioequivalence study
• Finished product Specification
• Certificate of free sale
• Certificate of import drug (Step 2)
29
Procedure
The subcom m ittee consider
Experts consider
O fficers consider
Asking for register pharm acopoeia
30
Procedure (Continue)
Approve
Approve Not approve
Reconsider
Correct/adjust Not approve
The subcom m ittee consider
33
Cost of Product
• Bioequivalence Study
• License for register, production, selling drug
• Quality control in production and environment
34
Regulation in Selling
• Producer must have license for sell drug
• Amount of selling must follow license
• Advertisement ; clearly, include side effect and no over/false the real properties